20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T79380 | Galectin-3/galectin-8-IN-1 | Galectin | |
Galectin-3/galectin-8-IN-1 (Compound 53) serves as a dual inhibitor of the Galectin-3 and galectin-8 C-terminal domains, exhibiting dissociation constants (Kd) of 4.12 μM for Galectin-3 and 6.04 μM for galectin-8. It eff... | |||
T79381 | Galectin-3/galectin-8-IN-2 | Galectin | |
Galectin-3/galectin-8-IN-2 (Compound 57) is a dual inhibitor targeting the C-terminal domains of Galectin-3 and galectin-8, exhibiting dissociation constants (Kd) of 12.8 μM and 2.06 μM, respectively. It effectively inhi... | |||
T64040 | Galectin-3-IN-2 | ||
Galectin-3-IN-2 is a potent inhibitor of polyvalent galactose lectin-3, with an IC50 value of 8.3 μM for Gal-3. Galectin-3 is involved in many metabolic processes associated with cancer. | |||
T74538 | Galectin-3 antagonist 2 | Galectin | |
Galectin-3, a β-galactoside-specific carbohydrate recognition protein (lectin), facilitates the migration of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells and demonstrates resistance to pharmaceutical int... | |||
T61014 | Galectin-8-IN-1 | ||
Galectin-8-IN-1 is a selective ligand for the galectin-8 N-terminal domain (galectin-8N) with a Kd value of 48 μM. Galectin-8-IN-1 is 15-fold more selective than galectin-3 and even better than other mammalian galectins. | |||
T62454 | Galectin-3-IN-1 | ||
Galectin-3-IN-1 (Compound 1) is a potent inhibitor of polyvalent galactose lectin-3 (Gal-3). Galectin-3 is involved in many metabolic processes associated with cancer. | |||
T82605 | DB21, Galectin-1 Antagonist | Galectin | |
DB21, Galectin-1 Antagonist, is a peptidomimetic conjugated with dibenzofuran, serving as an allosteric inhibitor of galectin-1 (GAL1) interactions with glycans on cell surfaces. This compound enhances the inhibition of ... | |||
TQ0265 | Indolelactic acid | Endogenous Metabolite | |
Indolelactic acid is a metabolite of tryptophan in Azotobacter vinelandii cultures. | |||
T16413 | OTX008 | Calixarene 0118,PTX008 | Galectin |
OTX008 (PTX008) is a selective galectin-1 inhibitor. | |||
T15372 | GB1107 | (2R,3R,4S,5R,6R)-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-4-[4-(3,4,5-trifluorophenyl)triazol-1-yl]oxane-3,5-diol | Galectin |
GB1107 is an effective and selective Galectin-3 inhibitor with a Kd of 37 nM. | |||
T5121 | TD139 | Galectin | |
TD139 is an inhaled galectin-3 inhibitor (Kd: 14 nM). | |||
T11346L | G3-C12 acetate(848301-94-0 free base) | Galectin | |
G3-C12 acetate shows anticancer activity. is a galectin-3 binding peptide, with Kd of 88 nM. | |||
T38074 | Thiodigalactoside | Galectin | |
Thiodigalactoside (TDG), a non-metabolizable disaccharide, serves as an orally active, potent galectin (GAL) inhibitor, exhibiting Kd values of 24 μM and 49 μM for GAL1 and GAL3, respectively. Demonstrating anti-inflamma... | |||
T11346 | G3-C12 | Others | |
G3-C12 shows anticancer activity. is a galectin-3 binding peptide, with Kd of 88 nM. | |||
T75986 | G3-C12 TFA | ||
G3-C12 (TFA), a galectin-3 binding peptide, demonstrates anticancer activity with a dissociation constant (K d) of 88 nM. | |||
T69874 | LLS30 | ||
LLS30 is an allosteric inhibitor of Galectin-1 (Gal-1). LLS30 decreases Gal-1 binding affinity to its binding partners, and potentially overcomes metastatic castration-resistant prostate cancer (mCRPC). | |||
TP1294 | G3-C12 TFA (848301-94-0 free base) | G3-C12 TFA | |
G3-C12 TFA Salt is a specific galectin-3 binding peptide with Ksubdsub of 88 nM and shows anticancer activity. | |||
T63485 | Apoptosis inducer 8 | ||
Apoptosis inducer 8 is a galectin-1 (gal-1)-mediated apoptosis inducer and a PET imaging agent that significantly reduces gal-1 protein levels and can be used in major lung cancer studies worldwide. | |||
T16624 | Propargyl-PEG4-CH2CH2-Boc | Others | |
Propargyl-PEG4-CH2CH2-Boc is a PEG- and Alkyl/ether-based non-cleavable ADC linker. Propargyl-PEG5-Boc can used to synthesize ADC inhibitors of Galectin-3[1]. | |||
T16620 | Propargyl-PEG5-acid | Propargyl-PEG4-C2-acid | Others |
Propargyl-PEG5-acid is a non-cleavable 5 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Propargyl-PEG5-acid can used to synthesize ADC inhibitors of Galectin-3[1]. |